This article is more than 5 years old. Information may no longer be current.

Imperial Innovations invests in Stanmore Implants

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Imperial Innovations Group has made a £4 million investment in Stanmore Implants, a specialist in the design and manufacture of patient specific implants for complex orthopaedic reconstructions. Following the investment, Innovations will hold a substantial stake in Stanmore Implants, according to a company press release.

The proceeds will be used to expand Stanmore’s U.S. and U.K. sales forces for its current products and to support Stanmore’s development of its new technologies.

John Holden, director of investments at Innovations, is joining Stanmore’s Board as a non-executive director.

“This is an ideal opportunity for us to invest in a more developed business where we know and understand the value creation opportunities,” Susal Searle, Imperial Innovations chief executive officer, stated in the release. “We have worked closely with the Stanmore management team for some time and with our extensive knowledge of their business we are well positioned to support them as they enter the next stage of their development.”